Olopatadine Hydrochloride Solution/ Drops
Product Images NDC 62332-502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 62332-502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olopatadine-carton11 (Olopatadine Carton11)

Olopatadine-carton11 (Olopatadine Carton11)
This text is a product description for Olopatadine Hydrochloride Ophthalmic Solution, which is used to treat allergic conjunctivitis. The product comes in a 2.5mL bottle, with the usual dosage being one drop in each affected eye once a day. It is important not to touch the dropper tip to any surface to avoid contamination. The solution contains active ingredients, olopatadine hydrochloride, and a preservative, benzalkonium chloride. The product should be stored at 2°C to 25°C. The product is made in India and is manufactured by Gland Pharma Limited, Hyderabad.*
FDA Label Image

Olopatadine-container (Olopatadine Container)

Olopatadine-container (Olopatadine Container)
This is a prescription eye drop solution containing Olopatadine HCI in 2.5mL container, manufactured by Alembic Pharmaceuticals, Inc. The recommended dosage and storage instructions are available in the enclosed insert. It is made in India and distributed in the USA with NDC 62332-502-03 number. The drug is used for eye treatment, and the label warns against using it for any other purposes than stated. The batch expires in April 2019.*
FDA Label Image

Olopatadine-structure (Olopatadine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.